- Previous Close
23.80 - Open
22.80 - Bid 22.60 x 13000
- Ask 23.20 x 12300
- Day's Range
22.80 - 22.80 - 52 Week Range
22.80 - 27.40 - Volume
40 - Avg. Volume
0 - Market Cap (intraday)
428.813M - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
10.36 - EPS (TTM)
2.20 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield 0.65 (2.75%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
ZACROS Corporation provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. It operates through four segments: Wellness Business, Environmental Solutions Business, Electronic Materials Business, and Industrial Infrastructure Business. The company offers wellness products, including BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; MediTect IV Bag, an infusion bags; and Total Thrombus formation Analysis System, a flow chamber system. It also provides environmental solutions, such as flexible refill pouches; liquid containers; and clean packs and spout pouches. In addition, it offers protective films; coating commissioned processing services, release liners, and free standing electrode. Further, it provides construction and civil engineering products. The company offers its products under the ZACROS brand name. the company was formerly known as Fujimori Kogyo Co., Ltd. and changed its name to ZACROS Corporation in October 2024. ZACROS Corporation was founded in 1914 and is headquartered in Tokyo, Japan.
www.zacros.co.jp2,664
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: FJ3.F
View MorePerformance Overview: FJ3.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FJ3.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FJ3.F
View MoreValuation Measures
Market Cap
447.62M
Enterprise Value
306.12M
Trailing P/E
10.80
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.49
Price/Book (mrq)
0.79
Enterprise Value/Revenue
0.33
Enterprise Value/EBITDA
5.04
Financial Highlights
Profitability and Income Statement
Profit Margin
4.52%
Return on Assets (ttm)
4.41%
Return on Equity (ttm)
7.92%
Revenue (ttm)
147.78B
Net Income Avi to Common (ttm)
6.68B
Diluted EPS (ttm)
2.20
Balance Sheet and Cash Flow
Total Cash (mrq)
27.39B
Total Debt/Equity (mrq)
4.66%
Levered Free Cash Flow (ttm)
--